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Summary
Mitosis is thought to be triggered by the activation of
Cdk-cyclin complexes [1, 2]. Here we have used RNA
interference (RNAi) to assess the roles of three mitotic
cyclins, cyclins A2, B1, and B2, in the regulation of
centrosome separation and nuclear-envelope break-
down (NEB) in HeLa cells. We found that the timing
of NEB was affected very little by knocking down cy-
clins B1 and B2 alone or in combination. However,
knocking down cyclin A2 markedly delayed NEB, and
knocking down both cyclins A2 and B1 delayed NEB
further. The timing of cyclin B1-Cdk1 activation was
normal in cyclin A2 knockdown cells, and there was
no delay in centrosome separation, an event appar-
ently controlled by the activation of cytoplasmic cyclin
B1-Cdk1 [3]. However, nuclear accumulation of cyclin
B1-Cdk1 was markedly delayed in cyclin A2 knock-
down cells. Finally, a constitutively nuclear cyclin
B1, but not wild-type cyclin B1, restored normal NEB
timing in cyclin A2 knockdown cells. These findings
show that cyclin A2 is required for timely NEB,
whereas cyclins B1 and B2 are not. Nevertheless cy-
clin B1 translocates to the nucleus just prior to NEB
in a cyclin A2-dependent fashion and is capable of
supporting NEB if rendered constitutively nuclear.
Results and Discussion
We used diced siRNA pools (d-siRNAs) [4, 5] to sup-
press synthesis of cyclin A2 (the main A-type cyclin
present in somatic cells [6]) and cyclins B1 and B2 (the
best-studied B-type cyclins) in HeLa cells. Diced siRNA
pools were chosen because of their high efficacy [4, 5]
and low propensity for both off-target effects [7] and
interference with endogenous miRNA-processing
*Correspondence: delquin@stanford.edu (D.G.), james.ferrell@
stanford.edu (J.E.F.)pathways [8]. We synchronized cells by double thymi-
dine block and transfected them with the cyclin d-siRNAs
singly or in combination during the first thymidine wash-
out. 24 hr after transfection, cells were released from
the second thymidine block. We assessed cyclin levels
by immunoblotting (Figure 1A) and followed mitotic
progression by automated epifluorescence microscopy,
with a tdimer2-RFP-tagged fluorescent mitotic biosen-
sor (MBS) [9–11] that localizes to the nucleus during
interphase and translocates to the plasma membrane
upon NEB (Figure 1B).
All of the d-siRNA pools (25 nM) were found to be ef-
fective and specific (Figure 1A). Silencing was estimated
to be 82%–100% by quantitative western blotting (Fig-
ure 1A and data not shown) and 75%–80% by histone
H1 kinase assays of cyclin immunoprecipitates (see
below and data not shown). No cross-silencing was de-
tected (Figure 1A).
Surprisingly, there was less than an hour’s delay in
NEB in cells with cyclin B1, cyclin B2, or both B-type cy-
clins knocked down to low levels (Figure 1C). In con-
trast, there was a marked delay in NEB in the cyclin A2
knockdown cells (Figure 1C). Thus, cyclin A2 appears
to be critical for the progression of double thymidine-
arrested cells into prometaphase. The cyclin A2/B1 dou-
ble knockdown showed a substantial additional delay in
mitosis (Figure 1C). Thus, cyclin B1 becomes important
for NEB when cyclin A2 function is compromised.
These findings differ from those of a previous study
[12], where high concentrations of two cyclin B1 siRNAs
caused HeLa cells to accumulate in G2 phase. However,
the siRNAs used in that study substantially reduced
the levels of cyclin A2 as well as cyclin B1 [12]. It is pos-
sible that the effects seen in the previous study were
mediated by the combined knockdown of cyclins A2
and B1.
To determine whether the delay in NEB seen here in the
cyclin A2-knockdown cells was an off-target effect, we
made use of a cyclin A2 d-siRNA pool generated from
its 30-untranslated region (30-UTR). This cyclinA2 d-siRNA
pool knocked down cyclin A2 levels (Figure 1E) and
delayed mitotic entry (Figure 1F). Moreover, a cyclin A2
expression construct lacking the 30UTR restored cyclin
A2 levels (Figure 1E) and restored the timing of NEB to
nearly that seen in the GL3 knockdown/sham rescue cells
(Figure 1F, blue versus black points), while having little
effect on the timing of mitosis in cells transfected with
control (GL3) d-siRNAs (Figure 1F, gray versus black
points). Thus, the delay in NEB seen in the cyclin A2
knockdown cells was not attributable to off-targeteffects.
At least two mechanisms could account for the effect
of cyclin A2 knockdown on NEB. Cyclin A2 could be re-
quired for the completion of S phase, with the delayed
NEB being secondary to checkpoint activation, or it
could be important for the G2/M transition per se [13,
14]. To determine which was the case, we synchronized
cells, knocked down cyclin expression (Figure 2A), and
then measured DNA content by propidium iodide
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86Figure 1. The Timing of Mitotic Entry in HeLa Cells Treated with Cyclin d-siRNAs
(A–D) Cells were synchronized by double thymidine block and transfected with a mitotic biosensor (MBS) and various diced siRNAs.
(A) Cyclin levels of d-siRNA-treated HeLa cells as assessed by immunoblotting.
(B) Scoring NEB with the MBS. Four frames from a 14 hr time-lapse video are shown. The time stamps (in hours and minutes) indicate the time
after release from double thymidine block.
(C) The timing of NEB in d-siRNA-treated cells released from double thymidine block. Approximately 500 cells (442–540) were counted for each
treatment.
(D) Final cumulative % NEB 19 hr after release from double thymidine block. Data are expressed as means6 SE from six movies (two movies per
well, three wells per d-siRNA treatment).
(E and F) Rescue of normal mitotic timing with an RNAi-resistant cyclin A2 construct. Cells were synchronized by double thymidine block and
transfected with the MBS plus one of two diced siRNAs (GL3 d-siRNAs or d-siRNAs derived from the cyclin A2 30-UTR) and one of two rescue
constructs (a YFP ‘‘sham’’ rescue construct or a cyclin A2-YFP rescue construct lacking the cyclin A2 30-UTR).
(E) Cyclin levels of d-siRNA-treated HeLa cells at two time points, 5 hr and 20 hr after release from double thymidine block, as assessed by
immunoblotting. a-tubulin was used as a loading control.
(F) The timing of NEB in cells treated with d-siRNAs plus a cyclin A2 or a YFP sham rescue construct. Between 279 and 405 cells were counted for
each treatment. NEB was assessed by epifluroescence time-lapse microscopy. The bar graph (inset) shows the final cumulative % NEB at 19 hr,
expressed as means6 SE for data from three individual wells. Note that mitotic entry was consistently slower in cells transfected with 10 ng DNA
(E, F) than with 5 ng (A–D).staining and flow cytometry (Figure 2B). At the start of
the thymidine washout (0 hr), the control GL3 cells
were well synchronized with a G1 phase 2N DNA content
(Figure 2B). Most cells had entered S phase by 5 hr after
release and had nearly completed S phase by 8 hr
(Figure 2B). By 11 hr, postmitotic G1 cells were beginning
to appear. Mitosis was largely completed by 14 hr (Fig-
ure 2B). The cyclin A2 knockdown cells showed no
change in S phase progression, which was largely com-
pleted by 8 hr after release (Figure 2B). This wassurprising in light of previous reports showing that cyclin
A antibodies and antisense oligonucleotides inhibit DNA
replication in REF52 cells [13], HeLa cells, and human
foreskin fibroblasts [14]; perhaps those studies achieved
an even lower level of cyclin A2 function. However, the
cyclin A2 knockdown cells were delayed in the progres-
sion from a G2/M 4N DNA content to a G1 2N DNA con-
tent (Figure 2B). This indicates a role for cyclin A2 in mi-
totic entry or completion. There was a slight delay in the
completion of DNA replication in the cyclin A2/B1
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87Figure 2. DNA Content in d-siRNA-Treated
HeLa Cells Released from Double Thymidine
Block
(A) Cyclin levels 20 hr after release, as as-
sessed by immunoblotting.
(B) DNA content. Cells treated with various
cyclin d-siRNAs were harvested at various
times after release from double thymidine
block, fixed and stained with propidium
iodide, and subjected to flow cytometry to
assess DNA content.double-knockdown cells and A2/B1/B2 triple-knock-
down cells, but again the main delay was in the disap-
pearance of the G2/M peak and consequent appearance
of a postmitotic G1 peak. Thus, cyclin A2 function is im-
portant for mitosis per se; the delays cannot be ac-
counted for by delayed DNA replication. These results
agree well with a previous report showing that microin-
jection of cyclin A2/Cdk2 into G2 phase HeLa cells
causes premature entry into mitosis, and microinjection
of the amino terminus of p21Cip delays mitotic entry [15].
We also looked for phenotypic defects and changes in
the duration of mitosis in those cyclin knockdown cells
that did enter M phase. As described in the Supplemen-
tal Data (available online), knocking down cyclin B1 or
cyclin B2 individually had no apparent effect on the dura-
tion of prometaphase, metaphase, or anaphase. How-
ever, cyclin B1/B2 double-knockdown cells showed a
modest increase in duration of prometaphase as well
as qualitative defects in mitosis, suggesting redundant
roles for cyclins B1/B2 in mitotic progression (Figure S1).
The fact that knocking down cyclin A2 caused a
marked delay in NEB but knocking down cyclin B1 did
not (Figure 1C) indicates that cyclin B1 is not an essen-
tial mediator of cyclin A2’s effects. However, in Xenopus
egg extracts, the cyclin A-, cyclin B1-, and cyclin B2-Cdk
complexes are activated and inactivated in temporal
succession [16], raising the possibility that cyclin A2might regulate some aspect of cyclin B1 function. In
support of this hypothesis, it has been reported that cy-
clin A2 siRNAs and dominant-negative Cdk2 inhibit cy-
clin B1-Cdk1 activation in human primary fibroblasts
and U2-OS cells [17]. To test whether cyclin A2 regulates
cyclin B1-Cdk activation, we compared the timing of cy-
clin A2-Cdk and cyclin B1-Cdk activation in control cells
and cells transfected with cyclin d-siRNAs. Knocking
down cyclin A2 caused a marked reduction in cyclin
A2-associated histone H1 kinase activity, as expected
(Figure 3A). However, cyclin B1-associated histone H1
kinase activity was not measurably delayed (Figure 3B).
This suggests that cyclin A2 protein is not required for
activation of cyclin B1-Cdk complexes and that NEB is
delayed in the cyclin A2 knockdown cells despite normal
mitotic levels of cyclin B1-Cdk activity. In cyclin B1
knockdown cells, the cyclin B1-associated histone H1
kinase activity was markedly reduced (Figure 3B) and
the cyclin A2-associated H1 kinase activity was unaf-
fected (Figure 3A). These observations suggest that
the cyclin B1-Cdk and cyclin A2-Cdk complexes are ac-
tivated independently of each other.
The function of the cyclin B1-Cdk complex depends
not only upon its activity, but also upon its intracellular
localization. During interphase, cyclin B1-Cdk shuttles
between the cytoplasm and nucleus, with its equilibrium
favoring the cytoplasm in general and the centrosome in
Current Biology
88Figure 3. Cyclin-Cdk Activities and Localization in Cells Treated with Cyclin d-siRNAs
(A and B) Timing of cyclin A2-Cdk and cyclin B1-Cdk activation. Cells were treated with the indicated d-siRNAs, lysed at various times after
release from double thymidine block, and subjected to immunoprecipitation with cyclin A2 or cyclin B1 antibodies followed by histone H1 kinase
assays. Activities were quantified by phosphorimaging. Data are expressed as means 6 SE from four or five independent experiments.
(C) Montages of centrosome separation, cyclin B1 nuclear accumulation, and NEB in a GL3 knockdown cell and a cyclin A2 knockdown cell.
Movies of these cells are provided as Supplemental Data.
(D) Cumulative data on the timing of centrosome separation, nuclear accumulation of cyclin B1, and NEB in synchronized cells treated with GL3
or cyclin A2 d-siRNAs. Data are shown from 92 GL3-treated cells and 159 cyclin A2 knockdown cells.
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89Figure 4. Rescue of Normal NEB Timing by Expression of a Constitutively Nuclear Cyclin B1
(A) Expression levels of endogenous cyclin B1, WT-cyclin B1-YFP, and NLS-cyclin B1-YFP in GL3-treated and cyclin A2 knockdown cells (top).
The efficacy of the cyclin A2 knockdown was assessed by cyclin A2 immunoblotting (bottom).
(B) Localization of WT-cyclin B1-YFP and NLS-cyclin B1 in interphase cells. The localization of the mitotic biosensor (MBS) is shown for
comparison.
(C) The timing of NEB in cells treated with GL3 or cyclin A2 d-siRNAs plus one of three rescue constructs: YFP (sham), WT-cyclin B1-YFP, or
NLS-cyclin B1-YFP. Between 345 and 474 cells were counted for each treatment. NEB was assessed by epifluroescence time-lapse microscopy.
The bar graph (inset) shows the final cumulative % NEB at 19 hr, expressed as means 6 SE for data from three individual wells.
(D) Schematic depiction of the regulation of centrosome separation and NEB.particular [18–20]. Early in prophase, phosphorylated
cyclin B1, which is thought to indicate active cyclin
B1-Cdk1, becomes detectable at the centrosomes [3]
and presumably triggers centrosome separation [19].
Sometime later, cyclin B1 abruptly moves to the nu-
cleus, and shortly thereafter NEB occurs [21–23]. This
prompted us to ask whether the G2-delayed cyclin A2
knockdown cells possessed cytoplasmic or nuclear cy-
clin B1 and whether centrosome separation occurred
with normal timing.
We cotransfected synchronized cells with a cyclin
B1-YFP construct, cyclin A2 or control d-siRNAs, and
the MBS, and we monitored individual cells after release
from thymidine block. The fluorescent cyclin B1 allowed
us to assess the timing of centrosome separation, nu-
clear accumulation of cyclin B1, and NEB (Figures 3C
and 3D). The timing of NEB was confirmed with the
MBS (not shown). Expression of cyclin B1-YFP at levels
comparable to endogenous cyclin B1 (Figure 4A) wassufficient for reliable assessment of centrosome sepa-
ration and cyclin B1-YFP redistribution.
Two typical cells are shown in Figure 3C. The GL3-
treated cell shown underwent centrosome separation
11.8 hr after release from thymidine block. Over the
next 50 min, the separated centrosomes migrated to op-
posite sides of the nucleus and became more conspicu-
ous. By 55 min, the cyclin B1 fluorescence had abruptly
moved to the nucleus, with NEB following 5 min later
(Figure 3C). The cyclin A2 knockdown cell shown under-
went centrosome separation earlier—6.5 hr after release
from the thymidine block—but then remained with sepa-
rated centrosomes for more than 8 hr before undergoing
nuclear accumulation of cyclin B1 and NEB (Figure 3C).
Thus, centrosome separation had become decoupled
from NEB and the nuclear accumulation of cyclin B1 in
the cyclin A2 knockdown cells.
Overall, there was no apparent delay in centrosome
separation in the cyclin A2 knockdown cells (Figure 3D,(E) The interval between centrosome separation and NEB in GL3 knockdown cells and cyclin A2 knockdown cells. We included all cells that
carried out centrosome separation during the first 11 hr after release from double thymidine block (37 GL3 knockdown cells and 41 cyclin A2
knockdown cells) so that we could follow each cell for at least an additional 8 hr.
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90red vsus black points). However, the nuclear accumula-
tion of cyclin B1 and NEB were substantially delayed in
cyclin A2 knockdown cells (Figure 3D). The median inter-
val between centrosome separation and NEB was 1.2 hr
in the GL3 knockdown cells versus more than 8 hr in the
cyclin A2 knockdown cells (Figure 3E). Note that the
nuclear accumulation of cyclin B1-YFP was always tem-
porally abrupt, no matter how long the G2 delay, and
was always promptly followed by NEB.
If the nuclear translocation of cyclin B1 is important
for cyclin B1-Cdk1 function, then a constitutively nuclear
form of cyclin B1 might rescue a cyclin A2 knockdown
more effectively than wild-type cyclin B1. To test this hy-
pothesis, we expressed wild-type cyclin B1-YFP and a
cyclin B1-YFP chimera fused to an SV40 large T antigen
nuclear localization sequence (NLS-cyclin B1) in syn-
chronized HeLa cells. At the level of expression
achieved (Figure 4A), WT-cyclin B1-YFP was present
in the cytoplasm and concentrated in the centrosome
(Figures 4B, 3D), and NLS-cyclin B1-YFP was constitu-
tively nuclear (Figure 4B). We then examined the timing
of NEB in individual cells released from the thymidine
block. As shown in Figure 4C, WT-cyclin B1-YFP had
no apparent effect on the timing of NEB in the GL3
knockdown cells (gray versus black points), in agree-
ment with a previous report [22]. NLS-cyclin B1-YFP
was also unable to accelerate NEB, again in agreement
with a previous report ([22], see Figure 4C, blue versus
gray and black points). Thus, neither WT-cyclin B1-
YFP nor NLS-cyclin B1-YFP acted as a general acceler-
ant of entry into mitosis; NLS-cyclin B1-YFP evidently
still becomes activated at a normal time despite being
constitutively nuclear.
In contrast, transfection of NLS-cyclin B1-YFP re-
stored the timing of NEB nearly to normal in the cyclin
A2 knockdown cells (Figure 4C, red versus blue points).
Thus, when cells expressed modest levels of NLS-cyclin
B1-YFP (Figure 4A), cyclin A2 function became largely
dispensable for NEB. WT-cyclin B1-YFP was less effec-
tive at rescuing NEB (Figure 4C, red versus yellow
points), despite higher expression levels (Figure 4A).
This indicates that nuclear cyclin B1 can substitute for
cyclin A2 in triggering NEB, but cytoplasmic cyclin B1
cannot.
In summary, we have shown that knocking down cy-
clin A2 in HeLa cells caused a delay in the nuclear accu-
mulation of cyclin B1 (Figure 3D) and in NEB (Figure 1C),
but no apparent delay in DNA replication (Figure 2B), the
activation of cyclin B1-Cdk1 (Figure 3B), or centrosome
separation (Figures 3C and 3D). Knocking down cyclin
B1 delayed NEB by less than an hour (Figure 1C), al-
though in the background of a cyclin A2 knockdown,
knocking down cyclin B1 caused substantial additional
delay in NEB (Figure 1C). Expression of NLS-cyclin B1,
but not WT-cyclin B1, mitigated the effects of cyclin
A2 knockdown on the timing of NEB (Figure 4C). Knock-
ing down cyclin B2 individually or together with cyclins
A2 or B1 had little effect on the timing of NEB, but knock-
ing down both B-type cyclins did delay mitotic progres-
sion and resulted in qualitative abnormalities in mitosis
(Figure S1).
Figure 4D shows a simple model to account for these
observations. Cyclin B1-Cdk1 and cyclin A2-Cdk com-
plexes are depicted as being activated independently,since knocking down cyclin B1 had no apparent affect
on cyclin A2-associated H1 kinase activity or vice versa
(Figures 3A and 3B). Active cyclin B1-Cdk1 accumulates
at the centrosome [3] and, we suppose, triggers centro-
some separation in a cyclin A2-independent fashion
(Figure 3D). Cyclin B1-Cdk1 then abruptly accumulates
in the nucleus, with this accumulation requiring cyclin
A2 (Figure 3D). The nuclear accumulation of cyclin B1-
Cdk1 is regulated by phosphorylation of cyclin B1 at res-
idues in its N terminus [3, 24, 25]; it seems plausible that
cyclin A2-Cdk may regulate one or more of these phos-
phorylations. Shortly after cyclin B1 accumulates in the
nucleus, NEB occurs. This may be the normal trigger
for NEB, or it may reflect some structural change in the
nuclear envelope. In either case, the accumulation of cy-
clin B1 is not essential for NEB as long as cyclin A2 is
present (Figure 1C). Nevertheless, cyclin B1 can substi-
tute for cyclin A2 if it is targeted to the nucleus (Fig-
ure 4C). The ability of NLS-cyclin B1 to substitute for
cyclin A2, together with the lack of a strong phenotype
in the cyclin B1 knockdowns, implies that there may
be substantial overlap between the NEB-related targets
of cyclin B1-Cdk1 and cyclin A2-Cdk.
A number of variations on this scheme are possible.
For example, some small concentration of cyclin B1
may actually be required for NEB, but the extent of
knockdown needed to reveal this requirement was not
achieved in the present work. However, given the high
efficacy of the cyclin knockdowns, one would have to
assume that cyclin B1 is normally present in HeLa cells
in huge excess of what is required for NEB. Perhaps a
more plausible possibility is that cyclin B1 plays some
role in regulating NEB, but is not strictly required, with
some backup mechanism (for example cyclin A2 itself)
ensuring that NEB is not delayed more than an hour if
cyclin B1 function is compromised.
The present findings show that cyclin A2-Cdk, cyclin
B1-Cdk1, and the substrates that mediate NEB consti-
tute a coherent feed-forward system [25]: cyclin A2-
Cdk1 can influence NEB both directly and through stim-
ulating the nuclear accumulation of cyclin B1-Cdk1
(Figure 4D). In engineering, feed-forward systems are
often employed when it is desirable to prepare to re-
spond in the face of a brief stimulus, and then actually
respond in the face of a longer stimulus. Perhaps cyclin
A2-Cdk normally prepares the nucleus for NEB, which is
then triggered either by the abrupt relocation of cyclin
B1-Cdk1 to the nucleus, or, in the absence of cyclin
B1, by the sustained activation of cyclin A2-Cdk com-
plexes themselves.
Although the functional analysis of cyclins in animal
cells stretches back nearly two decades, as yet no sim-
ple consensus has emerged on which cyclins are impor-
tant for mitosis. In Xenopus egg extracts, cyclins B1 and
B2 appear to redundantly drive NEB [26]; it is less clear
whether an A-type cyclin is required [27, 28]. InDrosoph-
ila embryos, cyclins B and B3 appear to play redundant
roles in NEB [29, 30]. Cyclin A is required as well [29, 31],
although recent work suggests that this is because cy-
clin A is required for the inactivation of Cdh1 and the ac-
cumulation of cyclin B, cyclin B3, and Cdc25, rather than
because of a direct role in mitosis [32, 33]. The situation
may be different in HeLa cells, since cyclin B1 and B2
levels are not low in cyclin A2 knockdown cells (Figures
Regulation of Mitotic Entry by Cyclin A2
911A, 2A, and 4A), as would be expected if cyclin A2 were
required to suppress Cdh1 activation in G2 phase or
prophase. Nevertheless, the studies presented here
underscore the importance of cyclin A2 in NEB in HeLa
cells, in part through regulating the localization of cyclin
B1 and in part through cyclin B1/B2-independent
effects.
Supplemental Data
Supplemental Data include one figure, two movies (showing centro-
some separation, nuclear translocation of cyclin B1, and NEB in con-
trol and cyclin A2 knockdown cells), and Supplemental Experimental
Procedures and can be found with this article online at http://www.
current-biology.com/cgi/content/full/17/1/85/DC1/.
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